Roopa Kohli-Seth, MD
img_Roopa Kohli-Seth
DIRECTOR, INSTITUTE FOR CRITICAL CARE MEDICINE
PROFESSOR | Surgery
Are you a patient?
Specialties
Critical Care
  • Multi-center, Randomized, Sham-controlled, Double-blind, Ascending-dose Study of Extracorporeal Mesenchymal Stromal Cell Therapy (SBI-101 therapy) in Subjects with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy
  • Investigating genomic factors and microbiome features that impact CDI transmission and prognosis
  • Investigating the role of telomere length and telomerase activity in septic shock patients
  • MD, Drexel University College of Medicine-Center City

    Residency, Internal Medicine, Sinai-Grace Hospital/Detroit Medical Center

    Fellowship, Critical Care Medicine, Mount Sinai Hospital

    Certifications

    American Board of Internal Medicine

    Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

    Dr. Kohli-Seth has not yet completed reporting of Industry relationships.

    Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.